Wolverine Trading’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-6,430
Closed -$2.12M 7241
2021
Q3
$2.12M Buy
+6,430
New +$2.18M ﹤0.01% 2099
2021
Q2
Sell
-1,921
Closed -$595K 7001
2021
Q1
$595K Sell
1,921
-19,462
-91% -$6.23M ﹤0.01% 3471
2020
Q4
$6.93M Sell
21,383
-2,594
-11% -$717K 0.01% 881
2020
Q3
$6.53M Sell
23,977
-3,200
-12% -$922K 0.02% 718
2020
Q2
$6.53M Sell
27,177
-5,303
-16% -$1.06M 0.02% 673
2020
Q1
$4.84M Sell
32,480
-4,211
-11% -$699K 0.01% 779
2019
Q4
$6.14M Buy
36,691
+13,226
+56% +$2.45M 0.02% 953
2019
Q3
$4.13M Buy
23,465
+9,316
+66% +$2.01M 0.01% 975
2019
Q2
$3.69M Sell
14,149
-2,802
-17% -$743K 0.01% 1100
2019
Q1
$4.84M Sell
16,951
-1,492
-8% -$496K 0.01% 894
2018
Q4
$5.87M Sell
18,443
-32,972
-64% -$11.5M 0.02% 720
2018
Q3
$23.1M Buy
51,415
+32,381
+170% +$12.8M 0.05% 259
2018
Q2
$5.54M Hold
19,034
0.01% 797
2018
Q1
$5.54M Buy
+19,034
New +$4.82M 0.01% 797
2016
Q4
Sell
-2,068
Closed -$266K 5372
2016
Q3
$266K Buy
+2,068
New +$248K ﹤0.01% 3407

Other funds holding ABMD

Wolverine Trading's ABMD Position: Q4 2021 in Review

Wolverine Trading sold out of Abiomed Inc (ABMD) in Q4 2021, closing a stake of 6,430 shares — an estimated $2.12M sold.

Wolverine Trading first reported a position in ABMD in Q3 2016 and held it in 15 quarters. The position peaked at $23.1M in Q3 2018. 496 funds tracked by Wall St. Rank hold ABMD as of Q4 2021.

  • Wolverine Trading reported no remaining Abiomed Inc position as of Q4 2021 after selling out during the quarter.
  • Wolverine Trading sold 6,430 Abiomed Inc shares in Q4 2021, an estimated $2.12M.
  • Wolverine Trading first reported a position in Abiomed Inc in Q3 2016 and held it in 15 quarters.
  • Wolverine Trading's Abiomed Inc position peaked at $23.1M in Q3 2018.
  • 496 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2021.

Based on Wolverine Trading's 13F filing for Q4 2021, filed 14 Feb 2022.